The first Horizon Therapeutics Plc trade was made in Q2 2019.
Since then Ken Griffin bought shares nine more times and sold shares on eight occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -4.15 Million shares
Q4 2023
Avg closing price
$116.18
Price range
$115.93
-
$116.30
Sold 7.0% shares (-313 Thousand shares)
Q3 2023
Avg closing price
$107.45
Price range
$98.98
-
$115.74
Increased shares by 12.2% (+485 Thousand shares)
Q2 2023
Avg closing price
$105.50
Price range
$96.34
-
$112.38
Increased shares by 214.2% (+2.71 Million shares)
Q1 2023
Avg closing price
$110.54
Price range
$107.32
-
$113.50
Sold 53.6% shares (-1.46 Million shares)
Q4 2022
Avg closing price
$83.06
Price range
$61.58
-
$113.80
Increased shares by 501.2% (+2.28 Million shares)
Q3 2022
Avg closing price
$69.87
Price range
$58.92
-
$84.67
Increased shares by 158.8% (+279 Thousand shares)
Q2 2022
Avg closing price
$94.70
Price range
$79.40
-
$116.36
Sold 85.6% shares (-1.04 Million shares)
Q1 2022
Avg closing price
$97.45
Price range
$86.42
-
$109.81
Sold 32.8% shares (-594 Thousand shares)
Q4 2021
Avg closing price
$109.09
Price range
$98.56
-
$119.91
Increased shares by 4.4% (+76.8 Thousand shares)
Q3 2021
Avg closing price
$103.81
Price range
$91.91
-
$110.37
Increased shares by 80.8% (+774 Thousand shares)
Q2 2021
Avg closing price
$92.03
Price range
$86.24
-
$95.92
Sold 25.4% shares (-327 Thousand shares)
Q1 2021
Avg closing price
$84.39
Price range
$71.83
-
$95.48
Sold 65.1% shares (-2.4 Million shares)
Q3 2020
Avg closing price
$68.81
Price range
$55.23
-
$79.93
Increased shares by 2.4% (+84.6 Thousand shares)
Q2 2020
Avg closing price
$42.78
Price range
$30.20
-
$56.98
Increased shares by 163.2% (+2.23 Million shares)
Q1 2020
Avg closing price
$33.83
Price range
$24.87
-
$38.56
Increased shares by 173.6% (+867 Thousand shares)
Q4 2019